Fibrinogen: Structure, Function, and Central Role in Hemostasis

Fibrinogen (Factor I) is a 340 kDa plasma glycoprotein synthesized in the liver. It is the essential substrate for clot formation, bridging platelet aggregation and fibrin mesh generation.

Molecular Structure

• Dimer of three paired chains: (Aα, Bβ, γ)₂ — six chains total.
• N-terminal E domain (central) connected via coiled-coil regions to two D domains.
• Plasma concentration: 2–4 g/L (200–400 mg/dL).
• Half-life: ~4 days; acute-phase reactant (↑ with inflammation).

Conversion to Fibrin

1. Thrombin cleaves fibrinopeptides A (FpA) and B (FpB) from Aα and Bβ chains.
2. Exposes polymerization sites ("knobs") that fit into complementary "holes" on adjacent molecules.
3. Forms protofibrils → branch into a 3D fibrin network.
4. Factor XIIIa (activated by thrombin) cross-links γ-γ and α-α chains → insoluble, stable clot.

Role in Coagulation Pathways

• Common pathway: Final substrate for both intrinsic and extrinsic thrombin generation.
• Platelet binding: Fibrinogen bridges activated GPIIb/IIIa receptors on adjacent platelets (primary aggregation).
• Clot structure: Fibrin density, fiber thickness, and porosity determine clot stability and lysis resistance.

Clinical Relevance

• Hypofibrinogenemia (congenital or acquired: DIC, liver failure, massive transfusion) → bleeding.
• Dysfibrinogenemia (qualitative defects) → bleeding or thrombosis.
• Fibrinogen concentrate and cryoprecipitate used for targeted replacement.

Fibrinogen sits at the nexus of coagulation, platelet function, and fibrinolysis—making it indispensable for hemostasis.